Recent Updates
Recently added Catalysts
PRAX Positive Sentiment Score: 60/100

Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference

Thursday, August 3, 2023 1 min read
Key Takeaway: Praxis Precision Medicines, a clinical-stage biopharmaceutical company, will participate in the 2023 Wedbush PacGrow Healthcare Conference on August 9, 2023. The company's management will be on a panel discussing the acceleration and broadened reach of orphan epilepsy development. This involvement emphasizes their focus on therapies for central nervous system disorders, specifically addressing neuronal excitation-inhibition imbalance. Interested parties are encouraged to contact their Wedbush representative for participation details.

Market Sentiment Analysis

POSITIVE FACTORS

  • Praxis Precision Medicines is actively participating in notable healthcare conferences.
  • The focus on orphan epilepsy development can enhance its visibility and reach.
  • The involvement in discussions about CNS disorders highlights their commitment to the field.

Full Press Release Details

BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate at the 2023 Wedbush PacGrow Healthcare Conference on Wednesday, August 9, 2023 at 9:30a.m. ET on the panel David vs. Goliath - How Can Orphan Epilepsy Development Accelerate and Broaden its Reach? Please contact your Wedbush representative for details about how to participate.

Contact Data

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.

Frequently Asked Questions

What is the focus of Praxis Precision Medicines?

Praxis Precision Medicines develops therapies for CNS disorders caused by neuronal imbalance.

When is Praxis participating in the Wedbush Conference?

Praxis will join the Wedbush Conference on August 9, 2023, at 9:30 a.m. ET.

What topic will Praxis discuss at the conference?

They will cover orphan epilepsy development and its broader impact.

How can I participate in the Wedbush Conference?

Contact your Wedbush representative for participation details.

Tags: PRAX Viatris Investor Conferences Healthcare CNS disorders orphan epilepsy healthcare conference biopharmaceutical
Last updated: Aug 3, 2023